Engitix

Developer of technology for in vitro drug discovery

placeLondon, England, United Kingdom calendar_todayFounded 2016 groups16 employees language engitix.com

Registered entities

Innovation

2 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 46 times.

YearFilings
20191
20201
20221
20231

Social engagement

Social engagement: 9K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Netherton Investments.

Investor typeCountShare
Venture capital18%
Other / undisclosed1292%

Recent activity

12 Jun 2026
Event
The Extracellular Matrix Pharmacology Congress
8 Jun 2026
Partnership
GSK
27 May 2026
Event
Antibody Engineering & Therapeutics Europe 2026
Coming soon